Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Wnt3a ELISA Kit (AC2508)
Cat.#: ASET-1097
Specifications
Description Mouse Wnt3a ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Wnt3a concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.65 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1585 Rat iNOS ELISA Kit (AC2996) Quantitative inquiry ASET-2535 Mouse Kappa Opioid Receptor ELISA Kit (AC3946) Quantitative inquiry ASET-1841 Human LGI3 ELISA Kit (AC3252) Quantitative inquiry ASET-1863 Human Oxytocin Receptor ELISA Kit (AC3274) Quantitative inquiry ASET-2023 Human PAX8 ELISA Kit (AC3434) Quantitative inquiry ASET-1477 Mouse CaMKII beta ELISA Kit (AC2888) Quantitative inquiry ASET-1335 Human Neurocan ELISA Kit (AC2746) Quantitative inquiry ASET-1171 Human SYT6 ELISA Kit (AC2582) Quantitative inquiry ASET-1594 Human NRSN2 ELISA Kit (AC3005) Quantitative inquiry ASET-1968 Mouse EGR3 ELISA Kit (AC3379) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket